<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Ovarian-Longevity on 生物经济</title><link>https://cn.bioecon.ru/technologies/ovarian-longevity/</link><description>Recent content in Ovarian-Longevity on 生物经济</description><generator>Hugo</generator><language>zh-CN</language><lastBuildDate>Sun, 28 Jun 2026 14:47:32 +0700</lastBuildDate><atom:link href="https://cn.bioecon.ru/technologies/ovarian-longevity/index.xml" rel="self" type="application/rss+xml"/><item><title>FemTech 生物技术与女性健康</title><link>https://cn.bioecon.ru/technology/femtech-biotech-womens-health/</link><pubDate>Sun, 28 Jun 2026 00:00:00 +0000</pubDate><guid>https://cn.bioecon.ru/technology/femtech-biotech-womens-health/</guid><description>针对专发或好发于女性的疾病开发生物药、药品与诊断系统——无创子宫内膜异位症检测、卵巢长寿疗法、阴道微生物组活体生物药(LBP)与 cfDNA 产前筛查,在 FDA、EU IVDR/EMA 与 NMPA 监管下推进。</description></item></channel></rss>